STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-08-23
Here’s whether Bio-Techne Corp. (TECH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.30% over 10 days); RSI 55 — healthy momentum range; strong 1-year return of +33.9%; 3-month momentum positive (+50.0%). Currently 0.4% off its 52-week high. Score: +7/7.
TECH is in a confirmed uptrend, trading above both its 50-day ($68.87) and 200-day ($60.35) moving averages. An RSI of 54.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +33.9% compares to +20.5% for SPY (beat the market by 13.4%).
$10,000 invested 1 year ago→ $13,393 today
vs. S&P 500 (SPY) — same period beat market by 13.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($60.35)
✓Above 50-day MA ($68.87)
✓RSI(14) neutral zone (30–70) — currently 54.8
✓Positive return (+33.9%)
✓Within 10% of period high (−0.4%)
Period Range $72.32
$43.20$72.62
RSI (14) 54.8
0 · OversoldOverbought · 100
Key Metrics
Price$72.32
Period Return+33.9%
Period High$72.62
Period Low$43.20
Drawdown−0.4%
MA-50$68.87
MA-200$60.35
RSI (14)54.8
Avg Volume (30d)3.4M
vs. SPYbeat by 13.4%
Return Rank#321 of 999
Trend Signals
Price is above the 200-day moving average ($60.35)